NDC 46708-184-03 - Telmisartan and Amlodipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46708-184
- Requested NDC
- 46708-184-03
- Package NDCs from labels
- 46708-184-03, 46708-184-10, 46708-184-30
- Manufacturer
- Alembic Pharmaceuticals Limited
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan and Amlodipine - Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited | 2026-10-26 | Human Prescription Drug Label |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46708-184-08 | Telmisartan and Amlodipine | 8 in 1 BLISTER PACK | TABLET | 8 | 4 | |
| 46708-184-08 | Telmisartan and Amlodipine | 80 in 1 CARTON | TABLET | 80 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Apotex Corp. | 4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03 | 2026-09-03 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | GSMS, Incorporated | 9c0f83f4-06ad-4bb1-a8e3-dcac43b840cf | 2026-09-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 6efc0ef6-0424-44fc-a9ea-eb30c3b83239 | 2026-09-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | QPharma, Inc. | 5866d1ee-631d-d09e-e063-6294a90abe01 | 2026-08-20 | Warnings, Adverse reactions | 864V2Q084H |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Caring Mill Lubricant Eye Drops | GLYCERIN, POVIDONE | FSA Store Inc | 2f735cdf-6530-1adf-e063-6394a90ab16a | 2026-08-16 | Warnings | FZ989GH94E |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 57da6ef2-2e86-4e4d-90df-73a2a8cf97f6 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Redpharm Drug | 58336a97-807a-2859-e063-6294a90ad338 | 2026-08-04 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 91215664-6e19-4e04-9ae7-ab5664799426 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 58a67272-c4c7-4e2c-85a5-9d39034d12c3 | 2026-07-27 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Major Pharmaceuticals | edf9b22c-e37e-4b4e-8a64-20bb036c7d2d | 2026-07-27 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan | TELMISARTAN | Redpharm Drug | 5743c58e-deab-ac93-e063-6294a90ac1eb | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 1080fcea-a5da-499d-a855-690c13559071 | 2026-07-17 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | NuCare Pharmaceuticals, Inc. | 4926f00c-ee19-3e10-e054-00144ff88e88 | 2026-07-17 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 4ad016ec-e158-4325-9f45-4460cf78dd98 | 2026-07-16 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.